Amrize (NYSE:AMRZ) Sets New 1-Year Low – Should You Sell?

Amrize Ltd (NYSE:AMRZ) shares reached a new 52-week low on Thursday. The company traded as low as $36.75 and last traded at $36.7230, with a volume of 712856 shares. The stock had previously closed at $37.39.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Weiss Ratings lowered Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, August 31st. Oppenheimer reduced their price objective on Amrize from $62.00 to $55.00 and set an “outperform” rating on the stock in a research report on Friday, September 18th. DA Davidson initiated coverage on Amrize in a research note on Monday, August 24th. They set a “neutral” rating and a $50.00 price objective on the stock. William Blair set a $40.00 target price on Amrize in a research note on Wednesday, September 2nd. Finally, Morgan Stanley set a $63.00 price target on Amrize and gave the stock an “overweight” rating in a report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, Amrize currently has a consensus rating of “Hold” and an average target price of $53.24.

Amrize Trading Down 1.4%

The business has a fifty day moving average price of $44.10 and a two-hundred day moving average price of $50.33. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $20.39 billion, a PE ratio of 16.98, a PEG ratio of 1.32 and a beta of 0.04.

Amrize (NYSE:AMRZ) last posted its earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion during the quarter. Analysts expect that Amrize Ltd will post 2.46 EPS for the current fiscal year.

Amrize Dividend Announcement

The business also recently declared a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s payout ratio is 20.28%.

Insider Transactions at Amrize

In other Amrize news, insider Stephen S. Clark acquired 5,260 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the completion of the acquisition, the insider owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. This trade represents a 97.82% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jacques Sanche acquired 4,150 shares of the business’s stock in a transaction dated Wednesday, August 26th. The shares were bought at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the transaction, the director directly owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This trade represents a 73.90% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders acquired 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is owned by company insiders.

Institutional Investors Weigh In On Amrize

Hedge funds and other institutional investors have recently modified their holdings of the company. Pictet Asset Management Holding SA lifted its holdings in Amrize by 4.7% during the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company’s stock worth $283,017,000 after buying an additional 234,731 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of Amrize by 3.7% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock worth $263,371,000 after acquiring an additional 171,622 shares in the last quarter. Barclays PLC lifted its stake in Amrize by 95.4% during the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after purchasing an additional 2,253,431 shares during the last quarter. Vontobel Holding Ltd. lifted its stake in Amrize by 2.3% during the fourth quarter. Vontobel Holding Ltd. now owns 4,598,092 shares of the company’s stock worth $252,450,000 after purchasing an additional 105,511 shares during the last quarter. Finally, First Manhattan CO. LLC. boosted its holdings in Amrize by 20.0% in the fourth quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company’s stock valued at $218,305,000 after purchasing an additional 672,030 shares in the last quarter.

Amrize Company Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.